Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms
作者： Wolf Peter Hofmann , Eva Herrmann , Christoph Sarrazin , Stefan Zeuzem
DOI: 10.1111/J.1478-3231.2008.01896.X
关键词:
摘要: … Ribavirin is an old broad‐spectrum antiviral that is highly effective when used in … However, the molecular mechanisms by which ribavirin enhances early and sustained virological …
sci-hub.se 参考文章(91)
Yoko Tanabe, Naoya Sakamoto, Nobuyuki Enomoto, Masayuki Kurosaki, Eri Ueda, Shinya Maekawa, Tsuyoshi Yamashiro, Mina Nakagawa, Cheng‐Hsin Chen, Nobuhiko Kanazawa, Sei Kakinuma, Mamoru Watanabe, Synergistic Inhibition of Intracellular Hepatitis C Virus Replication by Combination of Ribavirin and Interferon-α The Journal of Infectious Diseases. ,vol. 189, pp. 1129- 1139 ,(2004) , 10.1086/382595
Jon P. Anderson, Richard Daifuku, Lawrence A. Loeb, Viral Error Catastrophe by Mutagenic Nucleosides Annual Review of Microbiology. ,vol. 58, pp. 183- 205 ,(2004) , 10.1146/ANNUREV.MICRO.58.030603.123649
Michael P Manns, John G McHutchison, Stuart C Gordon, Vinod K Rustgi, Mitchell Shiffman, Robert Reindollar, Zachary D Goodman, Kenneth Koury, Mei-Hsiu Ling, Janice K Albrecht, None, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. The Lancet. ,vol. 358, pp. 958- 965 ,(2001) , 10.1016/S0140-6736(01)06102-5
Robert E. Lanford, Bernadette Guerra, Helen Lee, Devron R. Averett, Brad Pfeiffer, Deborah Chavez, Lena Notvall, Catherine Bigger, Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons Journal of Virology. ,vol. 77, pp. 1092- 1104 ,(2003) , 10.1128/JVI.77.2.1092-1104.2003
Olle Reichard, Gunnar Norkrans, Aril Frydén, Jean-Henrik Braconier, Anders Sönnerborg, Ola Weiland, Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C The Lancet. ,vol. 351, pp. 83- 87 ,(1998) , 10.1016/S0140-6736(97)06088-1
Lotte Coelmont, Jan Paeshuyse, Marc P. Windisch, Erik De Clercq, Ralf Bartenschlager, Johan Neyts, Ribavirin Antagonizes the In Vitro Anti-Hepatitis C Virus Activity of 2′-C-Methylcytidine, the Active Component of Valopicitabine Antimicrobial Agents and Chemotherapy. ,vol. 50, pp. 3444- 3446 ,(2006) , 10.1128/AAC.00372-06
Isabelle Bougie, Martin Bisaillon, Initial binding of the broad-spectrum antiviral nucleoside ribavirin to the hepatitis C virus RNA polymerase Journal of Biological Chemistry. ,vol. 278, pp. 52471- 52478 ,(2003) , 10.1074/JBC.M308917200
Markus Cornberg, Holger Hinrichsen, Gerlinde Teuber, Thomas Berg, Uta Naumann, Christian Falkenberg, Stefan Zeuzem, Michael P Manns, Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C Journal of Hepatology. ,vol. 37, pp. 843- 847 ,(2002) , 10.1016/S0168-8278(02)00300-8
S. Crotty, C. E. Cameron, R. Andino, RNA virus error catastrophe: direct molecular test by using ribavirin. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 6895- 6900 ,(2001) , 10.1073/PNAS.111085598
T Asselah, I Bieche, S Narguet, A Sabbagh, I Laurendeau, M-P Ripault, N Boyer, M Martinot-Peignoux, D Valla, M Vidaud, P Marcellin, Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C Gut. ,vol. 57, pp. 516- 524 ,(2007) , 10.1136/GUT.2007.128611